Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
Alias
More Information
(2S)-1-(3-Mercapto-2-Methylpropionyl)-L-Proline; (S,S)-1-(D-3-Mercapto-2-Methyl-1-Oxopropyl)-L-Proline; 1-((2S)-3-Mercapto-2-Methylpropionyl)-L-Proline; Capoten; L-Captopril; Lopirin; Acepress
Brief Introduction
Angiotensin converting enzyme inhibitor can significantly reduce blood pressure and reduce cardiac load. It is also effective for different types of hypertension and heart failure. And diuretic hydrochlorothiazide into a compound, with the trade names of capozide and acezide.
Suppliers
View More Vendors (3) >
Alias
More Information
Milrinonum; 1,6-Dihydro-2-Methyl-6-Oxo-(3,4'-Bipyridine)-5-Carbonitrile; Primacor; Corotrop; Milrila; 6-Methyl-2-Oxo-5-Pyridin-4-Yl-1H-Pyridine-3-Carbonitrile; Corotrope; Milrinona; 2-Methyl-6-Oxo-1,6-Dihydro-3,4'-Bipyridine-5-Carbonitrile; 3-Cyano-6-Methyl-5-(4-Pyridyl)-2-Pyridone; 6-Methyl-5-(4-Pyridyl)-2-Pyridone-3-Carbonitrile; Ym-018
Brief Introduction
Cardiotonics that enhance cardiac contractility and directly dilate blood vessels
Suppliers
View More Vendors (3) >
CAS:79902-63-9
Molecular Formula:C25H38O5
Alias
More Information
(1S,3R,7S,8S,8Ar)-1,2,3,7,8,8A-Hexahydro-3,7-Dimethyl-8-[2-[(2R,4R)-Tetrahydro-4-Hydroxy-6-Oxo-2H-Pyran-2-Yl]Ethyl]-1-Naphthalenyl 2,2-Dimethyl-Butanoate; Zocor; Synvinolin; Sinvacor; Denan; Lipex; Lodales; Simvastatine; Cholestat; Colemin; Simovil; Medipo; Pantok; Simvastatina; Simvastatinum
Brief Introduction
This product is a hypolipidemic drug, used for Hypolipidemia.
Suppliers
View More Vendors (3) >
CAS:13171-25-0
Molecular Formula:C14H24Cl2N2O3
Alias
More Information
Vastarel F; Yoshimilon; 1-(2,3,4-Trimethoxybenzyl)Piperazine Dihydrochloride,Trimetazidine Dihydrochloride; Trimetazidine 3Hcl; Takkmint; Youmetazine
Brief Introduction
Trimetazidine hydrochloride belongs to other anti angina cardiovascular drugs. It protects the energy metabolism of cells under hypoxia or ischemia and prevents the decline of intracellular ATP level, so as to ensure the normal function of ion pump and the normal operation of transmembrane sodium potassium flow, and maintain the stability of intracellular environment.
Suppliers
View More Vendors (3) >
CAS:144701-48-4
Molecular Formula:C33H30N4O2
Alias
More Information
4'-[{1,4'-Dimethyl-2'-Propyl[2,6'-Bi-1H-Benzimiaszol]-1'Yl}-Methyl}-1,1'-Biphenyl-2-Caroxylic Acid Dimethyl Ethyl Ester; 4'-[{1,4'-Dimethyl-2'-Propyl[2,6'-Bi-1H-Benzimiaszol]-1'Yl}-Methyl}-1,1'-Biphenyl-2-Caroxylic Acid; 4''-(1,7''-Dimethyl-2''-Propyl-1H-[2,5'']Bibenzoimidazolyl-3''-Ylmethyl)-Biphenyl-2-Carboxylic Acid; 4-Chloromethyl-5-Methyl-1,3-Dioxol-2-Tone; 4'-(1,7'-Dimethyl-2'-Propyl-1H-; Bibr 277, 4μ[(1,4μ-Dimethyl-2μ-Propyl[2,6μ-Bi-1H-Benzimidazol]-1μ-Yl)Methyl][1,1μ-Biphenyl]-2-Carboxylic Acid; 4'-[[4-Methyl-6-(1-Methyl-2-Benzimidazolyl)-2-Propyl-1-Benzimidazolyl]Methyl]-2-Biphenylcarboxylic Acid; Telmisartan,4′[(1,4′-Dimethyl-2′-Propyl[2,6′-Bi-1H-Benzimidazol]-1′-Yl)Methyl][1,1′-Biphenyl]-2-Carboxylic Acid, Bibr 277
Brief Introduction
Telmisartan is a new type of antihypertensive drug, which is a specific angiotensin II receptor antagonist for the treatment of essential hypertension. The substitution of angiotensin Ⅱ receptor for at Ⅰ receptor subtype has high affinity binding. Telmisartan has no agonist effect at the at I receptor site, but selectively binds to at I receptor, which is persistent. It has no affinity for other receptors. The function of other receptors mentioned above is unknown, and the possible receptor hyperstimulation effect caused by telmisartan is also unknown. Telmisartan did not inhibit plasma renin or block ion channels. It did not inhibit angiotensin converting enzyme II, which could also degrade bradykinin induced adverse reactions.
Suppliers
View More Vendors (3) >
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!